跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ORAVERSE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ORAVERSE
Authorized
STANDARD
ORAVERSE
Septodont
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9b6aa43e56712276
Company
Septodont
Type
Standard
Approval Details
Approval Id
9b6aa43e56712276
Drug Approval Canada Name
ORAVERSE
Product Name
ORAVERSE
Status
Marketed
Status Date
2014-09-17
Original Market Date
2014-09-17
Din
02421666
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Submucosal
Schedule
Prescription
Ahfs
12:16.04.04
Atc Original
V03AB36 PHENTOLAMINE
Atc Name
v 03 ab 36
Aig Number
0107611003
Company Name
Septodont
Company Address
58 Rue Du Pont De Creteil, St-Maur-Des-Fosses, Val-De-Marne, France, 94107
Company Detail Path
/organization/septodont
Company Information
Pharmaceutical Company Name
Septodont
Country Name
Belgium
Website
http://www.lamaire.be
Active Ingredients
PHENTOLAMINE MESYLATE
0.4 MG / 1.7 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9b6aa43e56712276
Type
Standard
Back to Health Canada Approvals